Skip to main content
. 2021 Aug 24;9(10):e1791. doi: 10.1002/mgg3.1791

TABLE 2.

Detailed clinical and molecular characteristics of 25 Korean patients with RSTS

Patient C‐01 C‐02 C‐03 C‐04 C‐05 C‐06 C‐07 C‐08 C‐09
Chief complaint DD Multiple anomaly Multiple anomaly DD DD DD DD DD DD
Sex (M:F) M F M M F M M M F
Maternal preeclampsia
NICU care + + +
Growth profile
Short stature at diagnosis + + + + +
Microcephaly at diagnosis + + + + + +
Short stature at last follow‐up + + + +
Obesity a at last follow‐up + +
Clinical phenotype
Hypertrichosis + + + + + + + +
Low ant hairline + + + + + + +
Arched eyebrows + + + + + + + +
Long eyelashes + + + + + + +
Narrow forehead + + + + + + +
Convex nasal ridge + + + + + + +
Large nose + + + +
Columella below alae nasi + + + + + + + +
High arched palate + + + + + +
Micrognathia + + + + +
Low‐set ears + +
Broad thumbs + + + + + + + +
Angulated thumbs + +
Broad halluces + + + + + + + +
Polydactyly + + +
Strabismus +, BIO myectomy +, BIO myectomy + +, BIO myectomy +, BIO myectomy +, BIO myectomy +
Other eye problem

+,

glaucoma‐like disc

+, ONLD

+,

optic disc coloboma

Congenital heart defect +, ASD +, PDA +, PDA
Genitourinary problem

+, VUR grade 4,

cryptorchidism

orchipexy

+, cryptorchidism

orchipexy

+, micropenis

+, cryptorchidism

orchipexy

Gastrointestinal problem +, GER +, GER +, GER +, GER +
Scoliosis +
Other bone problem +, funnel chest
Seizure +
CNS abnormality +, tethered cord syndrome +, Suspected posterior PVWM volume loss +, Chiari malformation type I +, delayed myelination
Keloid +
Malignant tumor +, ALL
Intellectual disability, IQ + + + + + +, 40 +, 47 + +
Age at walk alone (month) 21 27 24 27 32 40 20
Autism + +
Aggressive behavior
Genetic background
Causative gene CREBBP CREBBP CREBBP CREBBP CREBBP CREBBP CREBBP CREBBP CREBBP
Variant type Frameshift Frameshift Frameshift intragenic large deletion Frameshift Frameshift Frameshift intragenic large deletion nonsense
Exon exon 13 exon 3 exon 8 exon 25 exon 31 exon 30 exon 16
Coding sequence c c.2469_2470del c.955_961del c.1712_1716del c.4189_4192del c.5948del c.4944dup c.3121C>T
Protein‐based sequence d p.Gln823Hisfs*8 p.Val319Thrfs*33 p.Ile571Asnfs*13 p.Phe1397Leufs*61 p.Pro1983Glnfs*16 p.Pro1983Glnfs*16 p.Gln1041*
Exonic deletion exon 6–31 del exon 6–31 del
C‐10 C‐11 C‐12 C‐13 C‐14 C‐15 C‐16 E‐01 E‐02 E‐03 E‐04
DD DD DD Dysmorphic face DD Seizure, known CP Dysmorphic face DD Dysmorphic face DD DD
F M F M M F M F M M M
+
+ + + +
+ + + + + + +
+ + + +
+ + + + + + +
+
+ + + + + + b + + +
+ + + + + +
+ + + + + + +
+ + + + + +
+ + + + + +
+ + + + + +
+ + + +
+ + + + + +
+ + +
+ + +
+
+ + + + + + + + +
+
+ + + + + + + +
+ +
+, visual impairment +, ptosis
+, ASD +, ASD + +, PDA
+, Orchiopexy + Orchiopexy, micropenis +, Orchiopexy +
+ + + +
+ +
+, Anterior wedging of T11‐12 spine +, left coronal synostosis +, dislocation of radial head
+
+, arachnoid cyst +, Chiari I malformation +, Tethered cord syndrome +, Moyamoya disease +, inferior vermian hypoplasia
+, 34 + + + + +, 34 + + + +, 52 +, 51
42 24 24 48 26 14 15
+
+ +
CREBBP CREBBP CREBBP CREBBP CREBBP CREBBP CREBBP EP300 EP300 EP300 EP300
Intragenic large deletion Nonsense Intragenic large deletion Intragenic large deletion Frameshift Frameshift Intragenic large deletion Splicing variant Frameshift Frameshift Frameshift
Exon 17 Exon 27 Exon 27 Intron 24 Exon 27 Exon 5 Exon 14
c.3307C<T c.4400_4401del c.4482dup c.4173‐2A>G c.4384C>T c.1179_1180del c.2520del
p.Arg1103* p.Val1467Aspfs*11 p.Lys1495Glnfs*24 Exon 25 skipping p.Arg1462* p.Ala394Ilefs*16 p.Thr841Profs*9
Exon 1 del Exon 6–31 del Exon 1–3 del Exon 17–31 del
U‐01 U‐02 U‐03 U‐04 U‐05
Keloid DD DD
F M F M M
+
+
+ + + +
+
+
+ +
+
+
+
+
+
+
+
+ + +
+
+ +
+
+
+, Congenital glaucoma +, ONLD +, Epiblepharon +, Secondary glaucoma, coloboma,
+ +
+, Orchiopexy +, Orchiopexy +, VUR
+
+
+ +
+ +, 53 +, 46 +
21 23
UN UN UN UN UN

Abbreviations: ALL, acute lymphoblastic leukemia; ASD, atrial septal defect; BIO myectomy, bilateral inferior oblique myectomy; DD, developmental delay; GER, gastroesophageal reflux; IQ, intelligence quotient; ONLD, obstruction of the nasolacrimal duct; PDA, patent ductus arteriosus; UN, unknown; VUR, vesicourinary reflux.

a

Body mass index ≥95th percentile for children or ≥25.0 kg/m2 for adults.

b

Typical face, but no detailed medical records.

c

References for coding sequences are NM_004380.3 for CREBBP and NM_001429.4 for EP300.

d

References for protein‐based sequences are NP_004371.2 for CREBBP and NP_001420.2 for EP300.